Please wait a minute...
浙江大学学报（医学版）
Journal of ZheJiang University(Medical Science)  2016, Vol. 45 Issue (1): 1-4    DOI: 10.3785/j.issn.1008-9292.2016.01.01
    
Kyoto global consensus report for treatment of Helicobacter pylori and its implications for China
XIE Chuan, LYU Nonghua
Department of Gastroenterology, the First Affiliated Hospital, Nanchang University, Nangchang 330006, China
Download:   PDF(803KB)
Export: BibTeX | EndNote (RIS)      

Abstract  

Kyoto global consensus report on Helicobacter pylori gastritis (Gut, July 2015) is another important international consensus since the European Maastricht Ⅳ consensus was published. Kyoto consensus will improve the etiology-based classification, the diagnostic assessment of gastritis, and the treatment of H. pylori-associated dyspepsia and H. pylori gastritis. However, because of high rate of H. pylori infection and antibiotic resistance as well as limited health resources in China, we need to develop our own strategies of H. pylori infection control with the reference of the Kyoto global consensus.

Key words： Helicobacter pylori      Infection      Gastritis/etiology      Gastritis/diagnosis      Gastritis/therapy     
Received: 26 November 2015     
CLC:  R573.3  
Service
E-mail this article
Add to my bookshelf
Add to citation manager
E-mail Alert
RSS
Articles by authors
Cite this article:

XIE Chuan, LYU Nonghua. Kyoto global consensus report for treatment of Helicobacter pylori and its implications for China. Journal of ZheJiang University(Medical Science), 2016, 45(1): 1-4.

URL:

http://www.zjujournals.com/xueshu/med/10.3785/j.issn.1008-9292.2016.01.01     OR     http://www.zjujournals.com/xueshu/med/Y2016/V45/I1/1


京都全球共识对中国幽门螺杆菌感染治疗的启示

《幽门螺杆菌胃炎京都全球共识报告》于2015年7月在《消化道》(Gut)杂志全文发表。该共识对胃炎的病因学分类、诊断评估、幽门螺杆菌(Hp)感染相关消化不良及Hp胃炎治疗理念进行了革新,是继欧洲Maastricht Ⅳ共识之后发布的又一项有关Hp感染的重要国际共识。该共识的发布将有助于提高我国临床医师对Hp感染胃炎诊治的认识。但是,我国Hp感染人口基数大、抗生素耐药率高、卫生资源相对缺乏,因此临床实践中不能照搬国际共识,应制定适合我国国情的Hp感染诊治策略。


关键词： 螺杆菌,幽门,  感染,  胃炎/病因学,  胃炎/诊断,  胃炎/治疗 
[[1]]   SUGANO K, TACK J, KUIPERS E J, et al. Kyoto global consensus report on Helicobacter pylori gastritis[J]. Gut, 2015, 64(9):1353-1367.
[[2]]   MARSHALL B J, ARMSTRONG J A, MCGECHIE D B, et al. Attempt to fulfil Koch's postulates for pyloric campylobacter[J]. Med J Aust, 1985, 142(8):436-439.
[[3]]   TALLEY N J, VAKIL N B, MOAYYEDI P. American gastroenterological association technical review on the evaluation of dyspepsia[J]. Gastroenterology, 2005, 129(5):1756-1780.
[[4]]   MOAYYEDI P, SOO S, DEEKS J, et al. Systematic review and economic evaluation of Helicobacter pylori eradication treatment for non-ulcer dyspepsia. Dyspepsia Review Group[J]. BMJ, 2000, 321(7262):659-664.
[[5]]   房静远, 刘文忠, 李兆申,等. 中国慢性胃炎共识意见(2012年,上海)[J]. 中华消化杂志,2013, 33(1):5-16. FANG Jingyuan, LIU Wenzhong, LI Zhaoshen, et al. Consensus on chronic gastritis in China(2012, Shanghai)[J]. Chinese Journal of Digestion, 2013, 33(1):5-16.(in Chinese)
[[6]]   Chinese Society of Gastroenterology, Chinese Study Group on Helicobacter pylori, LIU W Z, et al. Fourth Chinese National Consensus Report on the management of Helicobacter pylori infection[J]. J Dig Dis, 2013, 14(5):211-221.
[[7]]   MALFERTHEINER P, MEGRAUD F, O'MORAIN C A, et al. Management of Helicobacter pylori infection——the Maastricht Ⅳ/Florence Consensus Report[J]. Gut, 2012, 61(5):646-664.
[[8]]   SACHS G, SCOTT D R. Helicobacter pylori:eradication or preservation[J]. F1000 Med Rep, 2012, 4:7.
[[9]]   LEE Y C, CHEN T H, CHIU H M, et al. The benefit of mass eradication of Helicobacter pylori infection:a community-based study of gastric cancer prevention[J]. Gut, 2013, 62(5):676-682.
[[10]]   MA J L, ZHANG L, BROWN L M, et al. Fifteen-year effects of Helicobacter pylori, garlic, and vitamin treatments on gastric cancer incidence and mortality[J]. J Natl Cancer Inst, 2012, 104(6):488-492.
[[11]]   ASAKA M, KATO M, SAKAMOTO N. Roadmap to eliminate gastric cancer with Helicobacter pylori eradication and consecutive surveillance in Japan[J]. J Gastroenterol, 2014, 49(1):1-8.
[[12]]   GRAHAM D Y. Helicobacter pylori update:gastric cancer, reliable therapy, and possible benefits[J]. Gastroenterology, 2015, 148(4):719-731.
[[13]]   HERRERO R, PARK J Y, FORMAN D. The fight against gastric cancer-the IARC Working Group Report[J]. Best Pract Res Clin Gastroenterol, 2014, 28(6):1107-1114.
[[14]]   XIE C, LU N H. Review:clinical management of Helicobacter pylori infection in China[J]. Helicobacter, 2015, 20(1):1-10.
[[15]]   GRAHAM D Y, FISCHBACH L. Helicobacter pylori treatment in the era of increasing antibiotic resistance[J]. Gut, 2010, 59(8):1143-1153.
[1] WANG Xue, ZHANG Yuchuan, CHEN Wei. Research progress on the role of TANK-binding kinase 1 in anti-virus innate immune response[J]. Journal of ZheJiang University(Medical Science), 2016, 45(5): 550-557.
[2] JI Yongjia, LU Hongzhou. Advances of immunological pathogenesis research in HIV related neurocognitive disorder[J]. Journal of ZheJiang University(Medical Science), 2016, 45(3): 249-255.
[3] ZHOU Yun, PAN Jianping. Progress on the role of Toll-like receptors in Candida albicans infections[J]. Journal of ZheJiang University(Medical Science), 2016, 45(3): 302-307.
[4] CHEN Siteng, YU Lixin, DENG Wenfeng, MIAO Yun, LIU Rumin, YE Guirong. Characteristics of urinary tract infection in kidney transplant recipients and non-recipient patients[J]. Journal of ZheJiang University(Medical Science), 2016, 45(2): 201-207.
[5] CUI Bi-jun, WANG Qing-qing . Immune function of interleukin33 and its relation to human diseases[J]. Journal of ZheJiang University(Medical Science), 2014, 43(3): 366-371.
[6] ZHOU Jun, WU Yi-dong, CHEN Xiao-ling, SONG Chao, YAN Jie. Epidemiological investigation of hand-foot-and-mouth disease in children and exposed population in Hangzhou city[J]. Journal of ZheJiang University(Medical Science), 2014, 43(2): 212-217.
[7] WU Li-juan, JIN Chang-zhong, BAI Shi, LIANG Yong, WU Nan-ping. Highly active antiretroviral therapy on liver function in HIV-positive children with HBV/HCV co-infection[J]. Journal of ZheJiang University(Medical Science), 2014, 43(2): 180-186.
[8] PEI Jingliang，FU Yurong. Research advance on bacteriophage therapy in bacterial infection[J]. Journal of ZheJiang University(Medical Science), 2013, 42(6): 700-704.
[9] PAN Jian-Ping, XIN Xiao-Li. Progress in TcpC research[J]. Journal of ZheJiang University(Medical Science), 2013, 42(5): 481-485.
[10] ZHENG Lin-Li, GE Yu-Mei, HU Wei-Lin, YAN Jie. Expression changes of major outer membrane protein antigens in Leptospira interrogans during infection and its mechanism[J]. Journal of ZheJiang University(Medical Science), 2013, 42(2): 156-163.
[11] . Effect of Helicobacter pylori infection on platelet activation and coagulation function in patients with acute cerebral infarction[J]. Journal of ZheJiang University(Medical Science), 2012, 41(5): 547-552.
[12] . Type I interferon and bacterial infection[J]. Journal of ZheJiang University(Medical Science), 2012, 41(4): 464-468.
[13] . Association of Helicobacter pylori infection and serum homocysteine level in patients with cerebral infarction[J]. Journal of ZheJiang University(Medical Science), 2012, 41(1): 89-92.
[14] . Research advances on regulation of Pseudomonas aeruginosa biofilm formation and its therapeutic strategies[J]. Journal of ZheJiang University(Medical Science), 2010, 39(1): 103-108.
[15] TENG Yi-qun, SUN Mei-yue, SHANG Shi-qiang. Polymerase Chain Reaction Amplification of 16 SrRNA Gene for the Detection of Bacterial Infection[J]. Journal of ZheJiang University(Medical Science), 1999, 28(5): 193-195.